(1 - 27 von 38
)
Billion-Euro Market Biotechnology: Exyte Builds mRNA ...AsiaOne
www.asiaone.com
— ... Melanie Käsmarker, Managing Director at Wacker Biotech GmbH. "In Exyte, we have the perfect partner for this project." "Biopharma and Life — ... Melanie Käsmarker, Managing Director at Wacker Biotech GmbH. "In Exyte, we have the perfect partner for this project." "Biopharma and Life ...
Billion-Euro Market Biotechnology: Exyte Builds mRNA ...PR Newswire UK
www.prnewswire.co.uk
— As such, the requirements for plant construction are just as high," says Melanie Käsmarker, Managing Director at Wacker Biotech GmbH. "In — As such, the requirements for plant construction are just as high," says Melanie Käsmarker, Managing Director at Wacker Biotech GmbH. "In ...
Wacker Biosolutions Under New LeadershipContract Pharma
www.contractpharma.com
— Effective the same date, Melanie Käsmarker becomes second managing director of Wacker Biotech GmbH. Currently, Ms. Käsmarker heads the — Effective the same date, Melanie Käsmarker becomes second managing director of Wacker Biotech GmbH. Currently, Ms. Käsmarker heads the ...
Wacker Chemie : Opens mRNA Competence Center in Halle ...marketscreener.com
www.marketscreener.com
— ... Melanie Käsmarker, co-managing director of Wacker Biotech GmbH, Egbert Geier, mayor of the city of Halle, Wolfgang Büchele, CEO of Exyte — ... Melanie Käsmarker, co-managing director of Wacker Biotech GmbH, Egbert Geier, mayor of the city of Halle, Wolfgang Büchele, CEO of Exyte ...
sortiert nach Relevanz / Datum